Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies

BACKGROUND: Health-related quality of life (HRQoL) may be markedly impaired in patients with moderate-to-severe psoriasis. OBJECTIVES: Our objectives were to compare improvements in Dermatology Life Quality Index (DLQI) and Psoriasis Symptoms and Signs Diary (PSSD) scores between patients receiving...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Clin Dermatol
Main Authors: Armstrong, April W., Reich, Kristian, Foley, Peter, Han, Chenglong, Song, Michael, Shen, Yaung-Kaung, You, Yin, Papp, Kim A.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2018
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513809/
https://ncbi.nlm.nih.gov/pubmed/30417277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40257-018-0396-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados